EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease

EphA2 receptor tyrosine kinase (RTK) is highly expressed in breast tumor cells across multiple molecular subtypes and correlates with poor patient prognosis. In this study, the potential role of EphA2 in this clinically relevant phenomenon is investigated as metastasis of breast cancer to bone is a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JBMR Plus
Egile Nagusiak: Vaught, David B, Merkel, Alyssa R, Lynch, Conor C, Edwards, James, Tantawy, Mohammed Noor, Hilliard, Timothy, Wang, Shan, Peterson, Todd, Johnson, Rachelle W, Sterling, Julie A, Brantley‐Sieders, Dana
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Inc. 2021
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8046157/
https://ncbi.nlm.nih.gov/pubmed/33869989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10465
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak